HER-2-targeted Herceptin-GNPs (30 nm) in combination with X-rays induced higher levels of DNA DSBs in HER2-positive human breast cancer cells than X-ray irradiation alone [86,87]. This evidence concerns the gene ERBB2 and breast cancer.